Character Bio
Transforming Eye Care With Precision Medicine
- Headquarters
- San Francisco, California
- Employees
- 11–50
- Founded
- 2021
- Business Model
- B2B
- Website
- characterbio.com
- Total Funding
- $110.0M
- Last Round
- $17.0M Extension RoundSep 2025
- Rounds
- 3
About
Character Bio is a precision medicine company focused on progressive polygenic eye diseases, with an initial focus on age-related macular degeneration (AMD) and primary open-angle glaucoma. The company integrates proprietary genomic databases with longitudinal clinical data, imaging, and AI-enabled biomarker quantification to identify patient subtypes and genetic drivers of disease progression. This platform underpins a drug discovery and development pipeline targeting more precise, individualized therapies.
Tech & App Stack
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingSign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sep 2025
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Create Free AccountInvestors
Sign up to view investors
Create a free account to see which investors have funded this company.
Create Free AccountSimilar Companies
Databricks is the pioneer of the data lakehouse, a unified platform for data science, machine lea...
Precisely is the global leader in data integrity, providing accuracy, consistency, and context in...
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Palantir Technologies builds data integration and analytics platforms (Gotham and Foundry) for go...
Cyera transforms the way organizations secure data in the cloud with Data Reality.
Data-centric infrastructure to accelerate the development of AI